Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Total Equity Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Total Equity
CHf155.6m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Equity
-$148.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Equity
CHf123.4m
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Equity
$1.9B
CAGR 3-Years
-8%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Equity
CHf16.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Kuros Biosciences AG
SIX:KURN
Total Equity
CHf60.2m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Total Equity?
Total Equity
155.6m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Total Equity amounts to 155.6m CHF.

What is Molecular Partners AG's Total Equity growth rate?
Total Equity CAGR 5Y
15%

Over the last year, the Total Equity growth was -24%. The average annual Total Equity growth rates for Molecular Partners AG have been 5% over the past three years , 15% over the past five years .

Back to Top